Partners' Directory

  Home   Search   Join the Partnership   Login

Contact General Specializations in Countries Contribution to the Global Plan Declaration

View this partner's profile

Organization Contact Information

Name: CIPLA
Street 1: Mumbai Central
Street 2:
City: MUMBAI
Province:
Post Code: 400.008
Country: India
Phone: +91 22 23082891
Email: sharadd.jain@cipla.com
Web Site: http://www.cipla.com

Focal Point Contact Information

Salutation: Dr.
First Name: Denis
Last Name: BROUN
Title: Director of public and government affairs
Email: denis.broun@cipla.com
Phone: +41.79.261.3137

Alternate Focal Point Contact Information

Salutation: Mr.
First Name: Sharadd
Last Name: JAIN
Title: Director Global Access
Email: sharadd.jain@cipla.com
Phone: +91.88791.24364

General Information

Board Constituency: Private sector
Organization Type - Primary: Private Sector
Organization Type - Secondary: Company
Is your organization legally registered in your country: Yes
Organization Reach: International
Organization Description:
Manufacturer of high quality medicines
Manufacturer of anti-TB drugs
Supplying TB drugs to low-income countries through our Global Access programme and supporting the development of new therapies for MDR-TB
 
Total number of staff in your organization: 100 +
Number of full-time staff who are directly involved with TB: 26 - 50
Number of part-time staff who are directly involved with TB: 100 +
Number of volunteers who are directly involved with TB: 0
 
What is your organization's annual budget (USD) dedicated to TB? >$10 MIL
How did you hear about the Stop TB Partnership: Involvement in TB control provision
If you were informed or referred by another partner of the Stop TB Partnership please tell us who:
Why do you wish join the Stop TB Partnership: Involvement in Stop TB Working Groups
 
Are you a member of a Stop TB national partnership: No
Are you in contact with your national TB programme: Yes
Please tell us how your organization is contributing to your country's national TB control plan:
SUpport through interaction with the national authorities in charge of the RNTCP and provision of medicines through government tenders
 

Geographical Reach

Which country is your headquarters located in: India
Which WHO region is the main focus of your work: Global
Which countries do you do operate in:
(This includes countries you are conducting activities in)
Afghanistan
Angola
Bangladesh
Bhutan
Burundi
Cambodia
Cameroon
Cape Verde
Central African Republic
Chad
Congo
Cote d'Ivoire
Democratic Republic of the Congo
Djibouti
Equatorial Guinea
Ethiopia
Gabon
Gambia
Ghana
Guinea
Guinea-Bissau
Haiti
India
Indonesia
Iran (Islamic Republic of)
Kazakhstan
Kenya
Kyrgyzstan
Lao People's Democratic Republic
Lesotho
Liberia
Madagascar
Malawi
Malaysia
Mali
Mauritania
Mauritius
Mexico
Mongolia
Morocco
Mozambique
Namibia
Nepal
Niger
Nigeria
Pakistan
Papua New Guinea
Peru
Philippines
Republic of Moldova
Russian Federation
Rwanda
Senegal
Seychelles
Sierra Leone
South Africa
South Sudan
Sri Lanka
Sudan
Swaziland
Switzerland
Tajikistan
Thailand
Tunisia
Turkey
Turkmenistan
Uganda
Ukraine
United Arab Emirates
United Kingdom of Great Britain and Northern Ireland
United Republic of Tanzania
United States of America
Uzbekistan
Venezuela
Viet Nam
Yemen
Zambia
Zimbabwe

Specializations

Provision of drugs, diagnostics and commodities

Specializations in Countries

Provision of drugs, diagnostics and commodities Afghanistan
Provision of drugs, diagnostics and commodities Angola
Provision of drugs, diagnostics and commodities Bangladesh
Provision of drugs, diagnostics and commodities Bhutan
Provision of drugs, diagnostics and commodities Burundi
Provision of drugs, diagnostics and commodities Cambodia
Provision of drugs, diagnostics and commodities Cameroon
Provision of drugs, diagnostics and commodities Cape Verde
Provision of drugs, diagnostics and commodities Central African Republic
Provision of drugs, diagnostics and commodities Chad
Provision of drugs, diagnostics and commodities Congo
Provision of drugs, diagnostics and commodities Cote d'Ivoire
Provision of drugs, diagnostics and commodities Democratic Republic of the Congo
Provision of drugs, diagnostics and commodities Djibouti
Provision of drugs, diagnostics and commodities Equatorial Guinea
Provision of drugs, diagnostics and commodities Ethiopia
Provision of drugs, diagnostics and commodities Gabon
Provision of drugs, diagnostics and commodities Gambia
Provision of drugs, diagnostics and commodities Ghana
Provision of drugs, diagnostics and commodities Guinea
Provision of drugs, diagnostics and commodities Guinea-Bissau
Provision of drugs, diagnostics and commodities Haiti
Provision of drugs, diagnostics and commodities India
Provision of drugs, diagnostics and commodities Indonesia
Provision of drugs, diagnostics and commodities Iran (Islamic Republic of)
Provision of drugs, diagnostics and commodities Kazakhstan
Provision of drugs, diagnostics and commodities Kenya
Provision of drugs, diagnostics and commodities Kyrgyzstan
Provision of drugs, diagnostics and commodities Lao People's Democratic Republic
Provision of drugs, diagnostics and commodities Lesotho
Provision of drugs, diagnostics and commodities Liberia
Provision of drugs, diagnostics and commodities Madagascar
Provision of drugs, diagnostics and commodities Malawi
Provision of drugs, diagnostics and commodities Malaysia
Provision of drugs, diagnostics and commodities Mali
Provision of drugs, diagnostics and commodities Mauritania
Provision of drugs, diagnostics and commodities Mauritius
Provision of drugs, diagnostics and commodities Mexico
Provision of drugs, diagnostics and commodities Mongolia
Provision of drugs, diagnostics and commodities Morocco
Provision of drugs, diagnostics and commodities Mozambique
Provision of drugs, diagnostics and commodities Namibia
Provision of drugs, diagnostics and commodities Nepal
Provision of drugs, diagnostics and commodities Niger
Provision of drugs, diagnostics and commodities Nigeria
Provision of drugs, diagnostics and commodities Pakistan
Provision of drugs, diagnostics and commodities Papua New Guinea
Provision of drugs, diagnostics and commodities Peru
Provision of drugs, diagnostics and commodities Philippines
Provision of drugs, diagnostics and commodities Republic of Moldova
Provision of drugs, diagnostics and commodities Russian Federation
Provision of drugs, diagnostics and commodities Rwanda
Provision of drugs, diagnostics and commodities Senegal
Provision of drugs, diagnostics and commodities Seychelles
Provision of drugs, diagnostics and commodities Sierra Leone
Provision of drugs, diagnostics and commodities South Africa
Provision of drugs, diagnostics and commodities South Sudan
Provision of drugs, diagnostics and commodities Sri Lanka
Provision of drugs, diagnostics and commodities Sudan
Provision of drugs, diagnostics and commodities Swaziland
Provision of drugs, diagnostics and commodities Switzerland
Provision of drugs, diagnostics and commodities Tajikistan
Provision of drugs, diagnostics and commodities Thailand
Provision of drugs, diagnostics and commodities Tunisia
Provision of drugs, diagnostics and commodities Turkey
Provision of drugs, diagnostics and commodities Turkmenistan
Provision of drugs, diagnostics and commodities Uganda
Provision of drugs, diagnostics and commodities Ukraine
Provision of drugs, diagnostics and commodities United Arab Emirates
Provision of drugs, diagnostics and commodities United Kingdom of Great Britain and Northern Ireland
Provision of drugs, diagnostics and commodities United Republic of Tanzania
Provision of drugs, diagnostics and commodities United States of America
Provision of drugs, diagnostics and commodities Uzbekistan
Provision of drugs, diagnostics and commodities Venezuela
Provision of drugs, diagnostics and commodities Viet Nam
Provision of drugs, diagnostics and commodities Yemen
Provision of drugs, diagnostics and commodities Zambia
Provision of drugs, diagnostics and commodities Zimbabwe

Contribution

Please tell us how your organization will contribute to the Global Plan to Stop TB by briefly describing its involvement in any of the areas of work listed below:

Drug-Resistant TB:
Supply of 7 anti-TB products used in MDR-TB

TB-HIV:
Second largest supplier of ARV in the world

New TB Drugs:
Involved in R&D for new TB products

Declaration

Declaration of interests:
CIPLA is a pharmaceutical company sellin medicines, including TB medicines. In addition, CIPLA participates in GDF tenders.


Application date: March 14, 2015
Last updated: March 20, 2015